Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19

NCT04423861 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

covid19

Interventions

DRUG: Nitazoxanide
DRUG: Placebo

Sponsor

Azidus Brasil

Collaborators

[object Object]